Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Puls

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
Investigative Radiology|August 10, 2001
Histopathological correlation to MRI findings during and after laser-induced thermotherapy in a pig pancreas modelC Stroszczynski, N Hosten, R Puls, et al.
HIV Medicine|December 14, 2011
Dynamics of cognitive change in HIV-infected individuals commencing three different initial antiretroviral regimens: a randomized, controlled studyA Winston, R Puls, S J Kerr, et al.
Clinical Pharmacology and Therapeutics|June 6, 2015
Pharmacokinetic and Pharmacodynamic Comparison of Once-Daily Efavirenz (400 mg vs. 600 mg) in Treatment-Naïve HIV-Infected Patients: Results of the ENCORE1 StudyL Dickinson, J Amin, L Else, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
Investigative Radiology|August 10, 2001
Histopathological correlation to MRI findings during and after laser-induced thermotherapy in a pig pancreas modelC Stroszczynski, N Hosten, R Puls, et al.
HIV Medicine|December 14, 2011
Dynamics of cognitive change in HIV-infected individuals commencing three different initial antiretroviral regimens: a randomized, controlled studyA Winston, R Puls, S J Kerr, et al.
Clinical Pharmacology and Therapeutics|June 6, 2015
Pharmacokinetic and Pharmacodynamic Comparison of Once-Daily Efavirenz (400 mg vs. 600 mg) in Treatment-Naïve HIV-Infected Patients: Results of the ENCORE1 StudyL Dickinson, J Amin, L Else, et al.
Pageof 6